Michel Geist
9Patents
3h-index
10Co-inventors
50Inventor score
Filing activity: Apr 12, 2001 → Dec 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8470977B2 | Antibody against the CSF-1R | Chemistry; Metallurgy | 26 | Active |
| US8604170B2 | Antibody against the CSF-1R | Chemistry; Metallurgy | 25 | Active |
| US10555981B2 | Oncolytic virus for expression of immune checkpoint modulators | Emerging Cross-Sectional Technologies | 3 | Active |
| US9428584B2 | Antibody against the CSF-1R | Chemistry; Metallurgy | 2 | Active |
| US9221912B2 | Antibody against the CSF-1R | Chemistry; Metallurgy | 2 | Active |
| US9982055B2 | Antibody against the CSF-1R | Chemistry; Metallurgy | 1 | Active |
| US7348014B2 | Poxvirus with targeted infection specificity | Chemistry; Metallurgy | 0 | Expired |
| US7354591B2 | Poxvirus with targeted infection specificity | Chemistry; Metallurgy | 0 | Expired |
| US11779619B2 | Oncolytic virus for expression of immune checkpoint modulators | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.